CME Group, the world's leading derivatives marketplace, today announced plans to launch Single Stock futures beginning this summer, pending completion of all regulatory review and processes. These new products will enable market participants to trade futures on more than 50 of the top U.S. stocks from the S&P 500, Nasdaq-100 and Russell 1000 indices, including names such as Alphabet, Meta, NVIDIA and Tesla – all with the flexibility, capital efficiency and precision of financially settled futures.
"We are pleased to begin offering investors an alternative way to gain exposure to individual leading U.S. stocks with our new Single Stock futures contracts," said Tim McCourt, Global Head of Equities, FX and Alternative Products at CME Group. "These contracts will provide a simpler, more cost-effective way to take a view on a stock, while allowing market participants to gain exposure to, or hedge potential price movements, without buying shares outright."
Demand for equity derivatives has been growing across both institutional and retail audiences in recent years, with new highs in 2025 including:
- Futures and options average daily volume (ADV) of 7.4 million contracts and open interest (OI) of 9.8 million contracts.
- Futures ADV of 6 million contracts, up 15% year-over-year, and record average OI of 5.6 million contracts, up 19% year-over-year.
The contracts will be listed on and subject to the rules of CME. For more information on these products, please visit cmegroup.com/ssf.
